1. Academic Validation
  2. Galactan isolated from Cantharellus cibarius modulates antitumor immune response by converting tumor-associated macrophages toward M1-like phenotype

Galactan isolated from Cantharellus cibarius modulates antitumor immune response by converting tumor-associated macrophages toward M1-like phenotype

  • Carbohydr Polym. 2019 Dec 15;226:115295. doi: 10.1016/j.carbpol.2019.115295.
Yue Meng 1 Yunhe Qu 1 Wenjing Wu 1 Lei Chen 1 Lin Sun 1 Guihua Tai 1 Yifa Zhou 1 Hairong Cheng 2
Affiliations

Affiliations

  • 1 Jilin Province Key Laboratory on Chemistry and Biology of Changbai Mountain Natural Drugs, School of Life Sciences, Northeast Normal University, Changchun 130024, PR China.
  • 2 Jilin Province Key Laboratory on Chemistry and Biology of Changbai Mountain Natural Drugs, School of Life Sciences, Northeast Normal University, Changchun 130024, PR China. Electronic address: [email protected].
Abstract

Tumor-associated macrophages (TAMs) with an M2-like phenotype have been linked to the proliferation, invasion and metastasis of tumor cells. Resetting tumor-associated macrophages represents an attractive target for an effective Cancer Immunotherapy. WCCP-N-b, a novel linear 3-O-methylated galactan, isolated from Cantharellus cibarius, can convert tumor-promoting M2-like macrophages to tumor-inhibiting M1-like phenotype. On a cellular mechanistic level, WCCP-N-b inhibited M2-like macrophages polarization through suppression of STAT6 activation. Furthermore, WCCP-N-b increased the phosphorylation of mitogen-activated protein kinases (MAPKs) and degradation of IκB-α through targeting Toll-like Receptor 2 (TLR2). The activation of MAPKs and degradation of IκB-α were responsible for converting M2-like macrophages to M1-like macrophages. Importantly, Cell Culture supernatants of WCCP-N-b-treated M2-like macrophages could inhibit the cell viability of B16F1 and B16F10. Our findings provide a potential natural and harmless polysaccharide for macrophage-based tumor immunotherapy.

Keywords

Anti-tumor; MAPK; Macrophages; NF-κB; TLR2; WCCP-N-b.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-100461
    ≥98.0%, TLR2 Inhibitor